Nine treatments of 1000 mL therapeutic phlebotomy in a subject with polycythemia: A case report.


Journal

Physiological reports
ISSN: 2051-817X
Titre abrégé: Physiol Rep
Pays: United States
ID NLM: 101607800

Informations de publication

Date de publication:
Jun 2024
Historique:
revised: 17 04 2024
received: 15 11 2023
accepted: 17 04 2024
medline: 7 6 2024
pubmed: 7 6 2024
entrez: 6 6 2024
Statut: ppublish

Résumé

Large-volume therapeutic phlebotomy is the mainstay of hemochromatosis treatment and offers an opportunity to investigate the hemodynamic changes during acute hypovolemia. An otherwise healthy 64-year-old male with hemochromatosis participated. On nine separate visits, 1000 mL therapeutic phlebotomy was performed. On one occasion, pre- and post-phlebotomy orthostatic challenge with 27° reverse Trendelenburg position was administered. Mean arterial pressure, heart rate, and stroke volume were measured continuously during the procedures. The patient's tolerance to the interventions was continuously evaluated. The procedures were well tolerated by the patient. Mean arterial pressure was maintained during hemorrhage and following phlebotomy in both supine and reverse Trendelenburg positions, primarily through an increase in heart rate and systemic vascular resistance. The present study found that 1000 mL therapeutic phlebotomy in a patient with hemochromatosis may be acceptably and safely used to model hemorrhage. The approach demonstrates high clinical applicability and ethically robustness in comparison with volunteer studies.

Identifiants

pubmed: 38844733
doi: 10.14814/phy2.16035
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e16035

Subventions

Organisme : Akershus Universitetssykehus (Ahus)
Organisme : Universitetet i Oslo, Institute of Basic Medical Sciences
Organisme : Faculty of Medicine, University of Oslo, Norway

Informations de copyright

© 2024 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society.

Références

Adams, S. D., & Holcomb, J. B. (2015). Geriatric trauma. Current Opinion in Critical Care, 21, 520–526.
Eriksen, M., & Walløe, L. (1990). Improved method for cardiac output determination in man using ultrasound doppler technique. Medical & Biological Engineering & Computing, 28, 555–560.
Goswami, N., Blaber, A. P., Hinghofer‐Szalkay, H., & Convertino, V. A. (2019). Lower body negative pressure: Physiological effects, applications, and implementation. Physiological Reviews, 99, 807–851.
Imholz, B. P., Wieling, W., Van Montfrans, G. A., & Wesseling, K. H. (1998). Fifteen years experience with finger arterial pressure monitoring: Assessment of the technology. Cardiovascular Research, 38, 605–616.
Johnson, B. D., Van Helmond, N., Curry, T. B., VAN Buskirk, C. M., Convertino, V. A., & Joyner, M. J. (2014). Reductions in central venous pressure by lower body negative pressure or blood loss elicit similar hemodynamic responses. Journal of Applied Physiology, 1985(117), 131–141.
Kirkman, E., & Watts, S. (2014). Haemodynamic changes in trauma. BJA: British Journal of Anaesthesia, 113, 266–275.
Kuchel, G. A., Avorn, J., Reed, M. J., & Fields, D. (1992). Cardiovascular responses to phlebotomy and sitting in middle‐aged and elderly subjects. Archives of Internal Medicine, 152, 366–370.
Matzen, S. H. (1995). Neuroendocrine mechanisms during reversible hypovolaemic shock in humans with emphasis on the histaminergic and serotonergic system. Acta Physiologica Scandinavica. Supplementum, 628, 1–31.
Murphree, C. R., Nguyen, N. N., Raghunathan, V., Olson, S. R., Deloughery, T., & Shatzel, J. J. (2020). Diagnosis and management of hereditary haemochromatosis. Vox Sanguinis, 115, 255–262.
Pearson, T. C., Ring, C. P., & Wetherley‐Mein, G. (1980). Plasma and whole blood viscosity in treated primary polycythaemia. Clinical and Laboratory Haematology, 2, 73–82.
Riley, D. S., Barber, M. S., Kienle, G. S., Aronson, J. K., Von Schoen‐Angerer, T., Tugwell, P., Kiene, H., Helfand, M., Altman, D. G., Sox, H., Werthmann, P. G., Moher, D., Rison, R. A., Shamseer, L., Koch, C. A., Sun, G. H., Hanaway, P., Sudak, N. L., KASZKIN‐Bettag, M., … Gagnier, J. J. (2017). CARE guidelines for case reports: Explanation and elaboration document. Journal of Clinical Epidemiology, 89, 218–235.
Shah, A., Kerner, V., Stanworth, S. J., & Agarwal, S. (2023). Major haemorrhage: Past, present and future. Anaesthesia, 78, 93–104.
Sloop, G., Holsworth, R. E., Weidman, J. J., & ST Cyr, J. A. (2015). The role of chronic hyperviscosity in vascular disease. Therapeutic Advances in Cardiovascular Disease, 9, 19–25.
World Medical Association. (2013). WMA declaration of Helsinki—Ethical principles for medical research involving human subjects. 64th WMA General Assembly. Retrieved November 4, 2020, from https://www.wma.net/policies‐post/wma‐declaration‐of‐helsinki‐ethical‐principles‐for‐medical‐research‐involving‐human‐subjects/

Auteurs

William J Morton (WJ)

Department of Anaesthesia, Akershus University Hospital, Lørenskog, Norway.
Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Department of Vascular Surgery, Oslo University Hospital, Oslo, Norway.

Anton Hauge (A)

Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.

Helge Opdahl (H)

Department of Acute Medicine, The Norwegian National CBRNE Medical and Advisory Centre, Oslo University Hospital, Oslo, Norway.

Erling Bekkestad Rein (EB)

Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.

Signe Søvik (S)

Department of Anaesthesia, Akershus University Hospital, Lørenskog, Norway.
Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.

Jonny Hisdal (J)

Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Department of Vascular Surgery, Oslo University Hospital, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH